IPSA EXAM QUESTIONS AND CORRECT
ANSWERS!
Which of the following does not describe the role of the pharmacist in POCT?
A. Gathering patient history and information regarding illness
B. Collecting testing specimen and processing it
C. Interpreting test results
D. Diagnosing a patient
Answer: D
Explanation: We can't always diagnose a patient with a condition. For example, in a blood
glucose test, we do not diagnose a patient with diabetes. We merely can find that their blood
sugar is elevated.
We can also determine if a patient is a candidate for POCT, and we can prescribe meds based on
available protocol or recommend OTCs
Which of the following describes a benefit for patients undergoing POCT?
A. Quick results
B. Convenient
C. Potential to decrease costs to the healthcare system
D. All of the above
Answer: D
Explanation: All of these are true. POCT also allows patients to play a more active role in their
care, also helping to reduce disease exposure.
Which of the following are potential benefits to pharmacists and pharmacies for
performing POCT?
,A. Increased revenue
B. Strengthen patient relationships
C. Stimulate demand for other services
D. All of the above
Answer: D
Explanation: Truth
Put the following steps prior to implementing Pharmacy-based POCT in order:
I. Create Bloodborne pathogens standards
II. Create Forms
III. Assess population need and ability to do a particular test
IV. Get patient consent
V. Create a policy and procedure manual (may or may not include a CPA)
VI. Get a CLIA certificate
A. I, II, III, IV, V, VI
B. III, I, II, VI, V, IV
C. III, VI, I, V, II, IV
D. III, VI, I, V, IV, II
Answer: C
Explanation: The slide in the powerpoint honestly doesn't make too much sense to me, probably
because I wasn't paying attention in class. If anyone has any way to make this better, please let
me know.
What does CLIA stand for?
A. Cholesterol Levels in Asthmatics
B. Clinical Laboratory Improvement Amendment
, C. Can (I) Leave Iowa, pleAse?
D. Clinical Laboratory Institution Assessment
Answer: B
Explanation: CLIA regulations need to be followed when providing any test requiring lab
samples (Cholesterol, glucose, INR, Strep, etc)
CLIAs are made to ensure quality of lab testing
True/False: CLIA are regulated by CMS
Answer: True
Explanation: I guess. Also, for the purposes of CLIA, your pharmacy is operating as the lab
when conducting these tests
Which of the following statements regarding CLIA is false?
A. CLIA requirements are based on complexity of tests performed
B. FDA categories the complexity of tests into 3 categories
C. Waived tests constitute the majority of pharmacy-based screenings
D. Waived tests can have a low to moderate risk if performed incorrectly
Answer: D
Explanation: Waived tests have to be simple to perform and have a low risk if incorrectly
performed. They should also have high accuracy.
The three types of tests are Waived tests, Tests of moderate complexity, and Tests of high
complexity
Which of the following can help improve prescription accuracy?
A. Recognize TALLman letters
ANSWERS!
Which of the following does not describe the role of the pharmacist in POCT?
A. Gathering patient history and information regarding illness
B. Collecting testing specimen and processing it
C. Interpreting test results
D. Diagnosing a patient
Answer: D
Explanation: We can't always diagnose a patient with a condition. For example, in a blood
glucose test, we do not diagnose a patient with diabetes. We merely can find that their blood
sugar is elevated.
We can also determine if a patient is a candidate for POCT, and we can prescribe meds based on
available protocol or recommend OTCs
Which of the following describes a benefit for patients undergoing POCT?
A. Quick results
B. Convenient
C. Potential to decrease costs to the healthcare system
D. All of the above
Answer: D
Explanation: All of these are true. POCT also allows patients to play a more active role in their
care, also helping to reduce disease exposure.
Which of the following are potential benefits to pharmacists and pharmacies for
performing POCT?
,A. Increased revenue
B. Strengthen patient relationships
C. Stimulate demand for other services
D. All of the above
Answer: D
Explanation: Truth
Put the following steps prior to implementing Pharmacy-based POCT in order:
I. Create Bloodborne pathogens standards
II. Create Forms
III. Assess population need and ability to do a particular test
IV. Get patient consent
V. Create a policy and procedure manual (may or may not include a CPA)
VI. Get a CLIA certificate
A. I, II, III, IV, V, VI
B. III, I, II, VI, V, IV
C. III, VI, I, V, II, IV
D. III, VI, I, V, IV, II
Answer: C
Explanation: The slide in the powerpoint honestly doesn't make too much sense to me, probably
because I wasn't paying attention in class. If anyone has any way to make this better, please let
me know.
What does CLIA stand for?
A. Cholesterol Levels in Asthmatics
B. Clinical Laboratory Improvement Amendment
, C. Can (I) Leave Iowa, pleAse?
D. Clinical Laboratory Institution Assessment
Answer: B
Explanation: CLIA regulations need to be followed when providing any test requiring lab
samples (Cholesterol, glucose, INR, Strep, etc)
CLIAs are made to ensure quality of lab testing
True/False: CLIA are regulated by CMS
Answer: True
Explanation: I guess. Also, for the purposes of CLIA, your pharmacy is operating as the lab
when conducting these tests
Which of the following statements regarding CLIA is false?
A. CLIA requirements are based on complexity of tests performed
B. FDA categories the complexity of tests into 3 categories
C. Waived tests constitute the majority of pharmacy-based screenings
D. Waived tests can have a low to moderate risk if performed incorrectly
Answer: D
Explanation: Waived tests have to be simple to perform and have a low risk if incorrectly
performed. They should also have high accuracy.
The three types of tests are Waived tests, Tests of moderate complexity, and Tests of high
complexity
Which of the following can help improve prescription accuracy?
A. Recognize TALLman letters
